Giuseppe Togni
- Infectious Diseases top 5%
- Epidemiology top 10%
- Molecular Biology
- Oncology
- Biotechnology top 5%
- Co-authors
- Michel MonodDominique SanglardBernhard HubeRocco FalchettoF. MaillandE. FrenkLila RahalisonAlessandro Subissi
- Topics
- Antifungal resistance and susceptibility (7 papers)COVID-19 Clinical Research Studies (5 papers)SARS-CoV-2 and COVID-19 Research (4 papers)
- Partner nations
- SwitzerlandUnited StatesItaly
In The Last Decade
Giuseppe Togni
22 papers receiving 881 citations
Peers
Comparison fields: 5 of 85
- Infectious Diseases 507
- Epidemiology 342
- Molecular Biology 291
- Oncology 210
- Biotechnology 151
Countries citing papers authored by Giuseppe Togni
This map shows the geographic impact of Giuseppe Togni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Togni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Togni more than expected).
Fields of papers citing papers by Giuseppe Togni
This network shows the impact of papers produced by Giuseppe Togni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Togni. The network helps show where Giuseppe Togni may publish in the future.
Co-authorship network of co-authors of Giuseppe Togni
This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Togni. A scholar is included among the top collaborators of Giuseppe Togni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Togni. Giuseppe Togni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 3 | |
| 3 | 3 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | 6 | |
| 7 | 12 | |
| 8 | 9 | |
| 9 | 18 | |
| 10 | 27 | |
| 11 | 107 | |
| 12 | 47 | |
| 13 | 23 | |
| 14 | 117 | |
| 15 | 218 | |
| 16 | 51 | |
| 17 | 11 | |
| 18 | 133 | |
| 19 | 71 | |
| 20 | 5 |
About Giuseppe Togni
Giuseppe Togni is a scholar working on Infectious Diseases, Biotechnology and Hepatology, having authored 23 papers that have together received 917 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (7 papers), COVID-19 Clinical Research Studies (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). The work is most often cited by research in Infectious Diseases (507 citations), Biotechnology (151 citations) and Epidemiology (342 citations). Giuseppe Togni has collaborated with scholars based in Switzerland, United States and Italy. Frequent co-authors include Michel Monod, Dominique Sanglard, Bernhard Hube, Rocco Falchetto, F. Mailland, E. Frenk, Lila Rahalison, Alessandro Subissi, Daniela Monti and Manfredo Quadroni. Their work appears in journals such as FEBS Letters, European Heart Journal and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.